GTR 94086086
Tenders Are Invited For Pharmaceutical Products - Completion Of Discount Contracts In Accordance With Section 130A (8) Sgb V For Medicines In The Generic Market
ICB — International Competitive Bid
Closed
Western Europe
Tender Information
GTR Reference
94086086
Tendering Authority
Subscribe to view
Tender No
170241-2025
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products - Completion Of Discount Contracts In Accordance With Section 130A (8) Sgb V For Medicines In The Generic Market
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Western Europe
Political Region
European Union,G20
Last Date of Bid Submission
30-04-2025
Closed
Work Detail
Pharmaceutical Products - Completion Of Discount Contracts In Accordance With Section 130A (8) Sgb V For Medicines In The Generic Market. Anastrozole,Buprenorphin-S (Sublingual Tablets) [Minimum Indication Substitution Treatment Of Opiate Addicts],Bupropion (Tablets With Changed Active Ingredient Release) [Only For The Treatment Of A Depressive Disease],Celecoxib,Dorzolamid,Ezetimib,Fentanyl (Matrix Pavement And Tablets),Formoterol,Hydromorphon Hydrochlorid,Levetiracetam,Methylphenidate [Minimum Indication Juvenile Adhd Therapy],Montelukast,Morphine (Only Medicines That Are Not Used For Opiative Cessation),Mycophenolic Acid (Moftil) [Only Fixed Oral Dosage Forms],Olmesartan+Amlodipin,Oxycodon Non-Ret (Just Non-Retarded Dosage Forms),Oxycodon Ret (Only Retarded Dosage Forms),Pantoprazole,Prasugrel,Ropinirol-F (Film-Coated Tablets) [Minimum Indication Parkinsons And Restlesslegens Disease Syndrome],Ropinirol-R (Retardtabletten),Sitagliptin,Sitagliptin+Metformin,Venlafaxin,Posaconazol Rm,Abirateron,Agomelatin,Alendronic Acid,Amitriptylin (Without Medicinal Products With The Active Ingredient Amitriptylinoxide),Aripiprazole (Tablets/Melt Tablets And Solutions To Take),Baclofen,Beclometasondipropionat,Betamethason,Bicalutamid,Bimatoprost+Timolol,Pressure,Brimonide,Brinzolamid+Brimonidin,Buprenorphin-P (Plaster),Cabergolin,Calcipotriol+Betamethasone (Ointments And Gels),Calcitriol,Candesartan+Amlodipin,Chlormadinon+Ethinylestradiol (Kalenderpackungen),Colecalciferol Rx,Darunavir,Dasatinib (Film -Coated Tablets),Desmopressin (Tablets And Sublingual Tablets),Dienogest,Dienogest+Ethinylestradiol,Domperidon,Dorzolamid+Timolol,Dutasteri+Tamsulosin,Iron (Iii) Ion (Without Drops To Take And Syrupe),Eplerenon,Esomeprazol,Everolimus (Tablets With The Atc (Who) L 01 Eg 02, Which Are Not Approved For Use In The Tsc (Tuberous Sclerosis Complex) Indication)),Ezetimib+Simvastatin,Febuxostat,Fenofibrat,Fluconazole,Fluoxetine,Fluticason 17-Propionat+Azelastin,Granisetron (Without Transdermal Plasters),Itraconazol,Lacosamid,Lactulose Non-Rx (Sirup),Lanreotide,Lansoprazol,Latanoprost + Timolol (Eye Drops With The Active Ingredient Thickness 50Μg/Ml + 5Mg/Ml In The Standard Pack Sizes 1-3 (N1-N3),Leflunomid,Lisdexamfetamine (Hard Capsules With The Pack Size 30 Pieces),Lorazepam,Melatonin (Retard Tablets With The Active Ingredient Strength 2Mg),Memant (Without Starter Packs),Metallaol,Methotrexate,Mometason Furoat,Olmesartan,Ondansetron,Opipramol,Oxcarbazepin,Oxybutynin,Paliperidone (Only Depot Injection Suspensions For A Month Dosage),Pirfenidon (Film -Coated Tablets),Pomalidomid,Posaconazol Eu-Ewr,Pramipexol,Pravastatin,Prednisolone,Propranolol,Ramipril+Amlodipin,Riluzol,Risedronic Acid,Roflumilast (Film -Coated Tablets And Tablets),Sevelamer Carbonate,Sildenafil (Film -Coated Tablets With The Active Ingredient Strength 20Mg),Telmisartan,Temozolomid,Terbinafin,Tolperison,Trospium Chlorid,Urapidil (Retard Capsule),Ursodeoxycholsäure,Vildagliptin+Metformin,Voriconazol,Xipamid,Zolpidem,Zopiclon
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
0b743bf8-825b-4cd8-bc98-c6ab57009df0.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.